UNSPSC 51283101: Anidulafungin

This classification denotes an antifungal agent with the molecular formula C58H73N7O17, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9HLM53094I, chemically known as echinocandin b, 1-((4r,5r)-4,5-dihydroxy-n2-((4-(pentyloxy)(1,1:4,1-terphenyl)-4-yl)carbonyl)-l-ornithine) but generally known as anidulafungin, which bears US NIH Compound Identifier 166548. European Medicines Agency schedules Anidulafungin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22240.

UNSPSC 51283101 Anidulafungin, a Commodity code, describes pharmaceutical active pharmaceutical ingredients and finished-dose antifungal medications. Recent state and local activity under this code shows minimal direct procurement of anidulafungin itself; instead, issuing bodies are using the code to tag broader pharmaceutical supply and emergency-response medication acquisitions. State and local governments procure finished pharmaceuticals—tablets, injectable formulations, and medical countermeasures—through cooperative purchasing vehicles, piggyback contracts, and competitive bidding. The issuing bodies soliciting under this code include state health departments and county public-health authorities responsible for emergency preparedness, community health operations, and strategic pharmaceutical stockpiles.

The most recent activity centers on Florida and Illinois. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026 (Solicitation 26482DPHPREPDB53392) for antibiotic tablets under an Invitation for Bid, with a total award of $2,999,999.11 across 12 months plus two renewal years. Seminole County, Florida issued an IFB (IFB60459723LAS) posted June 30, 2026 with a July 26, 2023 response deadline for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through quarterly deliveries; the procurement required electronic bid submission, included E-Verify and drug-free workplace compliance, and carried potential FEMA funding with associated federal regulatory obligations. The code shows sporadic state and local procurement activity; the records provided do not confirm anidulafungin as a directly solicited item in either opportunity.